Get started
Author

Hazem Ghebeh

Observed names: Ghebeh, Hazem, H Ghebeh, H. Ghebeh
Observed institutions: University of Fukui, Alfaisal University, Gunma University, King Faisal Specialist Hospital & Research Centre, King Fahad Specialist Hospital, University of Surrey, JIMRO (Japan), University of Manitoba
ORCID: 0000-0002-3297-3996
Observed ORCID: 0000-0002-3297-3996
OpenAlex ID: A5025251801
The B7-H1 (PD-L1) T Lymphocyte-Inhibitory Molecule Is Expressed in Breast Cancer Patients with Infiltrating Ductal Carcinoma: Correlation with Important High-Risk Prognostic Factors
2006 · Hazem Ghebeh, Shamayel Mohammed, et al. · Neoplasia · 628
PDF
Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: Significance in claudin-low breast cancer cells
2015 · Abdullah Alsuliman, Dilek Colak, et al. · Molecular Cancer · 294
PDF
PD‐L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation
2017 · Sheema Almozyan, Dilek Colak, et al. · International Journal of Cancer · 250
PDF
Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule
2010 · Hazem Ghebeh, Cynthia Lehe, et al. · Breast Cancer Research · 245
PDF
FOXP3+ Tregs and B7-H1+/PD-1+T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy
2008 · Hazem Ghebeh, Eman Barhoush, et al. · BMC Cancer · 213
PDF
Microvascular Injury, Thrombosis, Inflammation, and Apoptosis in the Pathogenesis of Heatstroke: A Study in Baboon Model
2008 · George T. Roberts, Hazem Ghebeh, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 175
Expression of B7‐H1 in breast cancer patients is strongly associated with high proliferative Ki‐67‐expressing tumor cells
2007 · Hazem Ghebeh, Asma Tulbah, et al. · International Journal of Cancer · 164
Breast Carcinoma–Associated Fibroblasts and Their Counterparts Display Neoplastic-Specific Changes
2008 · Nahed M. Hawsawi, Hazem Ghebeh, et al. · Cancer Research · 147
PD-L1 is overexpressed on breast cancer stem cells through notch3/mTOR axis
2020 · Fatmah A. Mansour, Amer Al-Mazrou, et al. · OncoImmunology · 120
PDF
Pluronic Enhances the Robustness and Reduces the Cell Attachment of Mammalian Cells
2008 · T. Tharmalingam, H. Ghebeh, et al. · Molecular Biotechnology · 112
Fascin Is a Key Regulator of Breast Cancer Invasion That Acts via the Modification of Metastasis-Associated Molecules
2011 · Monther Al-Alwan, Safiah Olabi, et al. · PLoS ONE · 101
PDF
Profiling of normal and malignant breast tissue show CD44high/CD24lowphenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers
2013 · Hazem Ghebeh, Ghida Majed Sleiman, et al. · BMC Cancer · 94
PDF
Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway
2016 · Rayanah Barnawi, Samiyah Al-Khaldi, et al. · Stem Cells · 85
Fascin is involved in the chemotherapeutic resistance of breast cancer cells predominantly via the PI3K/Akt pathway
2014 · H Ghebeh, S Al-Khaldi, et al. · British Journal of Cancer · 83
PDF
Novel CARMIL2 Mutations in Patients with Variable Clinical Dermatitis, Infections, and Combined Immunodeficiency
2018 · Anas M. Alazami, Maryam Al-Helale, et al. · Frontiers in Immunology · 72
PDF
Tocilizumab potentiates cisplatin cytotoxicity and targets cancer stem cells in triple‐negative breast cancer
2020 · Noura N. Alraouji, Falah H. Al‐Mohanna, et al. · Molecular Carcinogenesis · 65
β1 Integrin is essential for fascin‐mediated breast cancer stem cell function and disease progression
2019 · Rayanah Barnawi, Samiyah Al‐Khaldi, et al. · International Journal of Cancer · 55
PDF
Bi-allelic variants in HOPS complex subunit VPS41 cause cerebellar ataxia and abnormal membrane trafficking
2021 · Leslie E Sanderson, Kristina Lanko, et al. · Brain · 53
PDF
Differential marker expression by cultures rich in mesenchymal stem cells
2013 · Andrew Wetzig, Ayodele Alaiya, et al. · BMC Cell Biology · 48
PDF
Complete Response of Chemo-Refractory Metastatic Metaplastic Breast Cancer to Paclitaxel-Immunotherapy Combination
2019 · Adher D. Al Sayed, Mahmoud A. Elshenawy, et al. · American Journal of Case Reports · 44
The Wilms' Tumor Antigen Is a Novel Target for Human CD4+ Regulatory T Cells: Implications for Immunotherapy
2008 · Cynthia Lehe, Hazem Ghebeh, et al. · Cancer Research · 44
PDF
Senescent Breast Luminal Cells Promote Carcinogenesis through Interleukin-8-Dependent Activation of Stromal Fibroblasts
2018 · Huda H. Al-Khalaf, Hazem Ghebeh, et al. · Molecular and Cellular Biology · 41
Peripheral Blood Eosinophil Count is Associated with Response to Chemoimmunotherapy in Metastatic Triple-Negative Breast Cancer
2022 · Hazem Ghebeh, Mahmoud A Elshenawy, et al. · Immunotherapy · 39
CD3+T-lymphocyte infiltration is an independent prognostic factor for advanced nasopharyngeal carcinoma
2020 · Nasser Al-Rajhi, Hussein Soudy, et al. · BMC Cancer · 39
PDF
Therapeutic targeting of B7-H1 in breast cancer
2011 · Amal Hasan, Hazem Ghebeh, et al. · Expert Opinion on Therapeutic Targets · 39
Works count: 119
Citation count: 3,600
H-index: 28
I10-index: 37
Year
Topic
Type